Biotech group is showing signs of strength that imply a strong 2024.
The biotech group is poised to have a bullish 2024. Within the group, both Amgen and Gilead are strong holdings.
Stay updated with breaking news from Consensus Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The biotech group is poised to have a bullish 2024. Within the group, both Amgen and Gilead are strong holdings.
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
Shares edged lower at the open with Wall Street closed; Rebel Sport parent Super Retail expects first half revenue at $2b; Zenith hires Azure to review lithium business. Follow more updates here.
A U.S. stock rally that went too far, too fast, saw major indexes post their biggest drop in months Wednesday --- a welcome development to bulls looking for...
A U.S. stock rally that went too far, too fast, saw major indexes post their biggest drop in months Wednesday --- a welcome development to bulls looking for...